The role of NAD+ dependent histone deacetylases (sirtuins) in ageing
- PMID: 17100594
- DOI: 10.2174/1389450110607011553
The role of NAD+ dependent histone deacetylases (sirtuins) in ageing
Abstract
Histone deacetylases (HDACs) are enzymes that are able to deacetylate lysine side chains in histones and certain non-histone proteins which leads to altered states of conformation and activity for the proteins in question. Three classes of histone deacetylases have been recognized in humans. Class I and II are zinc-dependent amidohydrolases and eleven subtypes have been discovered (HDAC1-11). Class III enzymes depend in their catalysis on NAD(+) and subsequently, O-acetyl ADP ribose and nicotinamide are formed as a consequence of the acetyl transfer. Due to the homology to the yeast histone deacetylase Sir2p the NAD(+)-dependent deacetylases are also termed sirtuins and seven members (Sirt1-7) are known in humans. Sirtuins are found from bacteria to eukaryotes and altogether about 60 isoforms have been characterized in different organisms. Sirtuins have been implicated in the regulation of molecular mechanisms of aging. The overexpression of sirtuin enzymatic activity leads to an increase of lifespan in Saccharomyces cerevisiae and Caenorhabditis elegans that can also be reached by calorie restriction. Sirtuins have been proposed to act as sensors for glucose uptake that respond to the levels of NAD(+) but more complex ways of action have been suggested as well. This article will present the members of the human sirtuin family with their respective functions and review the existing druglike inhibitors and activators of sirtuin activity.
Similar articles
-
Inhibitors of NAD+ dependent histone deacetylases (sirtuins).Curr Pharm Des. 2008;14(6):562-73. doi: 10.2174/138161208783885380. Curr Pharm Des. 2008. PMID: 18336301 Review.
-
NAD(+) -dependent histone deacetylases (sirtuins) as novel therapeutic targets.Med Res Rev. 2010 Nov;30(6):861-89. doi: 10.1002/med.20178. Med Res Rev. 2010. PMID: 19824050 Review.
-
Inhibitors to understand molecular mechanisms of NAD(+)-dependent deacetylases (sirtuins).Biochim Biophys Acta. 2010 Oct-Dec;1799(10-12):726-39. doi: 10.1016/j.bbagrm.2010.06.003. Epub 2010 Jun 23. Biochim Biophys Acta. 2010. PMID: 20601279 Review.
-
Sirtuins: the 'magnificent seven', function, metabolism and longevity.Ann Med. 2007;39(5):335-45. doi: 10.1080/07853890701408194. Ann Med. 2007. PMID: 17701476 Review.
-
Acetyl-lysine analog peptides as mechanistic probes of protein deacetylases.J Biol Chem. 2007 Dec 21;282(51):37256-65. doi: 10.1074/jbc.M707878200. Epub 2007 Oct 19. J Biol Chem. 2007. PMID: 17951578
Cited by
-
Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer.J Pers Med. 2022 Oct 8;12(10):1672. doi: 10.3390/jpm12101672. J Pers Med. 2022. PMID: 36294811 Free PMC article.
-
Deacetylases and NF-kappaB in redox regulation of cigarette smoke-induced lung inflammation: epigenetics in pathogenesis of COPD.Antioxid Redox Signal. 2008 Apr;10(4):799-811. doi: 10.1089/ars.2007.1938. Antioxid Redox Signal. 2008. PMID: 18220485 Free PMC article. Review.
-
Histone Deacetylase Inhibitors as Anticancer Drugs.Int J Mol Sci. 2017 Jul 1;18(7):1414. doi: 10.3390/ijms18071414. Int J Mol Sci. 2017. PMID: 28671573 Free PMC article. Review.
-
Thienopyrimidinone Based Sirtuin-2 (SIRT2)-Selective Inhibitors Bind in the Ligand Induced Selectivity Pocket.J Med Chem. 2017 Mar 9;60(5):1928-1945. doi: 10.1021/acs.jmedchem.6b01690. Epub 2017 Feb 15. J Med Chem. 2017. PMID: 28135086 Free PMC article.
-
Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier.Theranostics. 2020 Jan 20;10(6):2463-2478. doi: 10.7150/thno.38973. eCollection 2020. Theranostics. 2020. PMID: 32194813 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous